AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35318529 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery Tracker (web-based patient-reported outcomes questionnaire)
Number of subjects: 23
Study 32658425 — intervention group
Group type: COMPARATOR
Intervention: Elecsys hGH assay
Number of subjects: 0
Study 32658425 — intervention group
Group type: COMPARATOR
Intervention: Elecsys IGF-1 assay
Number of subjects: 0
Study 36496154 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-management program (Pain EASE)
Number of subjects: 2529
Study 36496154 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored physical therapy program (Enhanced PT)
Number of subjects: 2529
Study 36496154 — intervention group
Group type: COMPARATOR
Intervention: Continued care with active monitoring (CCAM)
Number of subjects: 2529
Study 36496154 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for chronic pain (if re-randomized)
Number of subjects: 2529
Study 36496154 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation therapy (if re-randomized)
Number of subjects: 2529
Study 36496154 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (if re-randomized)
Number of subjects: 2529
Study 33558351 — intervention group
Group type: EXPERIMENTAL
Intervention: SISU software agent-based intervention, delivered over 3 consecutive days, based on therapeutic writing and acceptance and commitment therapy principles.
Number of subjects: 120
Study 33558351 — intervention group
Group type: EXPERIMENTAL
Intervention: SISU software agent-based intervention
Number of subjects: 120
Study 33558351 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 120
Study 33008464 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 30
Study 33008464 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin A supplementation)
Number of subjects: 30
Study 34235612 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray + oral antidepressant (AD)
Number of subjects: 1142
Study 34235612 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray + oral antidepressant (AD)
Number of subjects: 1142
Study 34235612 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray
Number of subjects: 1142
Study 34235612 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 1142
Study 32121286 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal functioning (Barkin Index of Maternal Functioning - BIMF)
Number of subjects: 530
Study 32121286 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health (Mental Health Inventory - MHI)
Number of subjects: 530
Study 32121286 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal functioning and mental health relationship
Number of subjects: 530
Study 32121286 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased maternal functioning
Number of subjects: 530
Study 36193847 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 13026
Study 33811556 — intervention group
Group type: EXPERIMENTAL
Intervention: continuous AG (cAG)
Number of subjects: 24
Study 33811556 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent AG (iAG)
Number of subjects: 24
Study 33811556 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 24
Study 32248089 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-SRG
Number of subjects: 11
Study 32248089 — intervention group
Group type: COMPARATOR
Intervention: SRG
Number of subjects: 11
Study 35734648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative antibiotics (intravenous cefazolin 2-g)
Number of subjects: 100
Study 35734648 — intervention group
Group type: COMPARATOR
Intervention: No pre-operative antibiotics
Number of subjects: 100
Study 33045448 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ovarian needle puncture prior to induction with aromatase inhibitors and gonadotropins
Number of subjects: 27
Study 33045448 — intervention group
Group type: COMPARATOR
Intervention: Induction using aromatase inhibitors (Letrozol 2.5 mg twice daily for 5 days) and FSH (75 IU daily from cycle day 3)
Number of subjects: 27
Study 33045448 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ovarian needle puncture
Number of subjects: 27
Study 33736523 — intervention group
Group type: COMPARATOR
Intervention: Statin prescription in HIV-negative patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin prescription in HIV-positive patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: COMPARATOR
Intervention: Aspirin prescription in HIV-negative patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin prescription in HIV-positive patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: COMPARATOR
Intervention: Smoking cessation counseling in HIV-negative patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling in HIV-positive patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers in HIV-positive patients
Number of subjects: 150
Study 33736523 — intervention group
Group type: COMPARATOR
Intervention: Current smokers in HIV-negative patients
Number of subjects: 150
Study 34209080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) - supervised exercise twice a week for 12 weeks
Number of subjects: 37
Study 34209080 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 37
Study 32686119 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand‐Arm Bimanual Intensive Therapy (HABIT) (90 hours)
Number of subjects: 41
Study 32686119 — intervention group
Group type: COMPARATOR
Intervention: Customary care (4.5 hours)
Number of subjects: 41
Study 34235875 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 105
Study 34235875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 32048945 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching model of communication skills for oncologists to facilitate GoC discussions
Number of subjects: 0
Study 32048945 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall productivity across four sites
Number of subjects: 0
Study 36180155 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-stretching with mindful breathing (MB)
Number of subjects: 30
Study 36180155 — intervention group
Group type: COMPARATOR
Intervention: Self-stretching without mindful breathing (Control)
Number of subjects: 30
Study 34548100 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health peri-operative cognitive-behavioral intervention (SurgeryPalTM)
Number of subjects: 0
Study 34548100 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36498075 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise with blood flow restriction (LLRE-BFR)
Number of subjects: 20
Study 36498075 — intervention group
Group type: COMPARATOR
Intervention: Low-load resistance exercise (LLRE)
Number of subjects: 20
Study 36498075 — intervention group
Group type: COMPARATOR
Intervention: Moderate-load resistance exercise (MLRE)
Number of subjects: 20
Study 32940695 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate caloric restriction (CR), 11.9% on average
Number of subjects: 218
Study 32940695 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate caloric restriction (CR)
Number of subjects: 218
Study 34908536 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (20 mg/kg)
Number of subjects: 50
Study 34908536 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (up to a serum level of 0.8‐1.5 mEq/L)
Number of subjects: 50
Study 32381151 — intervention group
Group type: EXPERIMENTAL
Intervention: VC injection pre-transit (5 g sodium ascorbate/steer)
Number of subjects: 90
Study 32381151 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline injection pre-transit and VC injection post-transit
Number of subjects: 90
Study 32381151 — intervention group
Group type: COMPARATOR
Intervention: Saline injection pre- and post-transit (CON)
Number of subjects: 90
Study 34510619 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of data limitations (technical)
Number of subjects: 1531
Study 34510619 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of data limitations (nontechnical)
Number of subjects: 1531
Study 34510619 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of clinical uncertainty (present)
Number of subjects: 1531
Study 34510619 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of clinical uncertainty (absent)
Number of subjects: 1531
Study 34510619 — intervention group
Group type: COMPARATOR
Intervention: Control (no disclosure)
Number of subjects: 1531
Study 32016585 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant cisternostomy (AC)
Number of subjects: 40
Study 32016585 — intervention group
Group type: COMPARATOR
Intervention: Decompressive craniectomy (DC)
Number of subjects: 40
Study 36460492 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated surgical warm-up procedure prior to surgery
Number of subjects: 147
Study 36460492 — intervention group
Group type: COMPARATOR
Intervention: Unprimed operative cases
Number of subjects: 147
Study 36460492 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming
Number of subjects: 147
Study 36460492 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy scores measured following priming
Number of subjects: 147
Study 35174636 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led social media intervention
Number of subjects: 89
Study 34085796 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) mapping
Number of subjects: 780
Study 34085796 — intervention group
Group type: COMPARATOR
Intervention: Pelvic lymphadenectomy
Number of subjects: 780
Study 32791379 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliable syntax condition
Number of subjects: 2
Study 32791379 — intervention group
Group type: COMPARATOR
Intervention: Reliable semantics condition
Number of subjects: 2
Study 35115023 — intervention group
Group type: EXPERIMENTAL
Intervention: Breaking the Man Code workshops
Number of subjects: 0
Study 35115023 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 34437978 — intervention group
Group type: EXPERIMENTAL
Intervention: Mast-cell inhibitors
Number of subjects: 326
Study 34437978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 36123051 — intervention group
Group type: EXPERIMENTAL
Intervention: Inforatio technique with usual care
Number of subjects: 100
Study 36123051 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 32853271 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm (SLATE II algorithm)
Number of subjects: 593
Study 32853271 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (usual care)
Number of subjects: 593
Study 34509670 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (short stay, discharge the day after the intervention)
Number of subjects: 42
Study 34509670 — intervention group
Group type: COMPARATOR
Intervention: Group A (conventional hospital stay of 2 to 3 days)
Number of subjects: 42
Study 33318126 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 16
Study 32193889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-CT index
Number of subjects: 2218
Study 32193889 — intervention group
Group type: COMPARATOR
Intervention: CTL-S
Number of subjects: 2218
Study 32193889 — intervention group
Group type: COMPARATOR
Intervention: Clinical indices
Number of subjects: 2218
Study 33524549 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA (eutectic mixture of lidocaine 2.5% and prilocaine 2.5%)
Number of subjects: 24
Study 33524549 — intervention group
Group type: COMPARATOR
Intervention: Capsaicin
Number of subjects: 24
Study 33524549 — intervention group
Group type: COMPARATOR
Intervention: EMLA alone
Number of subjects: 24
Study 32142084 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gram of pure eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), or docosahexaenoic acid (DHA) daily for 6 days
Number of subjects: 10
Study 32142084 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 10
Study 36414937 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary suckling technique with high or low protein milk-based formula supplement
Number of subjects: 108
Study 33229425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretomanid with rifampin
Number of subjects: 0
Study 33229425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretomanid with rifabutin
Number of subjects: 0
Study 33229425 — intervention group
Group type: COMPARATOR
Intervention: Pretomanid alone
Number of subjects: 0
Study 33229425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretomanid with food and rifampin
Number of subjects: 0
Study 32878631 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of unconjugated bilirubin (UCB) in men; per 1-SD increment of log-UCB
Number of subjects: 1386
Study 32878631 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of unconjugated bilirubin (UCB) in women; per 1-SD increment of log-UCB
Number of subjects: 1386
Study 32878631 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted higher levels of total bilirubin in men; per 1-SD increment of total bilirubin
Number of subjects: 1386
Study 32878631 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted higher levels of total bilirubin in women; per 1-SD increment of total bilirubin
Number of subjects: 1386
Study 35617820 — intervention group
Group type: EXPERIMENTAL
Intervention: Manufacturer group (IPS e.max ZirCAD MT A2)
Number of subjects: 15
Study 35617820 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush group (unshaded ceramic disc pigmented at the pre‐sintered stage)
Number of subjects: 15
Study 35617820 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersion group (unshaded ceramic disc pigmented through immersion)
Number of subjects: 15
Study 35617820 — intervention group
Group type: COMPARATOR
Intervention: Control group (non‐pigmented specimens)
Number of subjects: 15
Study 34334774 — intervention group
Group type: EXPERIMENTAL
Intervention: Short intervals (SIs)
Number of subjects: 18
Study 34334774 — intervention group
Group type: COMPARATOR
Intervention: Long intervals (LIs)
Number of subjects: 18
Study 32652012 — intervention group
Group type: EXPERIMENTAL
Intervention: ACGG + ATONU
Number of subjects: 829
Study 32652012 — intervention group
Group type: EXPERIMENTAL
Intervention: ACGG
Number of subjects: 829
Study 36463226 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-486 (300 mg daily on days 1-21 of a 28-day cycle)
Number of subjects: 49
Study 36463226 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 49
Study 32364091 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein protein (CP) 25 g
Number of subjects: 14
Study 32364091 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14
Study 33159632 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Autism Spectrum Therapy Observation System (PASTOS)
Number of subjects: 22
Study 33159632 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (manual-based)
Number of subjects: 22
Study 32857955 — intervention group
Group type: EXPERIMENTAL
Intervention: Stay-at-home orders (lockdowns)
Number of subjects: 2424
Study 35798178 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 101
Study 33439781 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tidal volume (Vt) ventilation strategies
Number of subjects: 1096
Study 33317593 — intervention group
Group type: EXPERIMENTAL
Intervention: REP+EF add IF
Number of subjects: 0
Study 33317593 — intervention group
Group type: COMPARATOR
Intervention: REP+EF/IF
Number of subjects: 0
Study 33317593 — intervention group
Group type: COMPARATOR
Intervention: REP+EF only
Number of subjects: 0
Study 35869933 — intervention group
Group type: EXPERIMENTAL
Intervention: low carbohydrate/high fat with high energy availability (LCHF)
Number of subjects: 28
Study 35869933 — intervention group
Group type: EXPERIMENTAL
Intervention: low energy availability (LEA)
Number of subjects: 28
Study 35869933 — intervention group
Group type: COMPARATOR
Intervention: high carbohydrate/high energy availability diet (CON)
Number of subjects: 28
Study 32951512 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial stress
Number of subjects: 65
Study 32951512 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 65
Study 35920954 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided by a protocol
Number of subjects: 193
Study 35920954 — intervention group
Group type: COMPARATOR
Intervention: Not guided by a protocol
Number of subjects: 193
Study 32187744 — intervention group
Group type: EXPERIMENTAL
Intervention: Language-motor intervention
Number of subjects: 108
Study 32187744 — intervention group
Group type: COMPARATOR
Intervention: Motor control
Number of subjects: 108
Study 32187744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 36502287 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Bodies intervention (high-intensity, family-based pediatric weight management)
Number of subjects: 396
Study 34585263 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA 10mg/kg
Number of subjects: 80
Study 34585263 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline in equal volumes)
Number of subjects: 80
Study 32513936 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT), 40 IU, administered as a single acute dose over 18–26 min post dosing.
Number of subjects: 47
Study 32513936 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered as a control treatment.
Number of subjects: 47
Study 35578302 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Acupuncture (TA)
Number of subjects: 84
Study 35578302 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Acupuncture (LA)
Number of subjects: 84
Study 35578302 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo intervention)
Number of subjects: 84
Study 34887656 — intervention group
Group type: EXPERIMENTAL
Intervention: RESP-FIT + Smartphone Airway Management System (SAMS) program, a 6-week, self-management, technology-enhanced respiratory muscle strength training (RMST) intervention
Number of subjects: 30
Study 34887656 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 30
Study 33989967 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized group (n = 76)
Number of subjects: 148
Study 33989967 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (n = 72)
Number of subjects: 148
Study 35253516 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg LSD
Number of subjects: 32
Study 35253516 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 µg LSD
Number of subjects: 32
Study 35253516 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 µg LSD
Number of subjects: 32
Study 35253516 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg followed by 75 µg LSD (1 week apart)
Number of subjects: 32
Study 35253516 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by 75 µg LSD (1 week apart)
Number of subjects: 32
Study 33795787 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-sparing protocol
Number of subjects: 56
Study 33795787 — intervention group
Group type: COMPARATOR
Intervention: Opioid-based protocol
Number of subjects: 56
Study 32307626 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor oral health knowledge, high dental anxiety, brushing teeth less than once a day, and regular consumption of chocolates or biscuits.
Number of subjects: 1207
Study 32307626 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingival bleeding
Number of subjects: 1207
Study 32307626 — intervention group
Group type: EXPERIMENTAL
Intervention: Father's education level (father went to college)
Number of subjects: 1207
Study 32307626 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher family income
Number of subjects: 1207
Study 35773666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigidfix femoral cross‐pin and Intrafix tibial extension sheath with tapered expansion screw
Number of subjects: 120
Study 35773666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigidfix femoral and BioScrew interference screw tibial fixation
Number of subjects: 120
Study 35773666 — intervention group
Group type: EXPERIMENTAL
Intervention: BioScrew femoral and Intrafix tibial fixation
Number of subjects: 120
Study 35773666 — intervention group
Group type: EXPERIMENTAL
Intervention: BioScrew fixation into both tunnels
Number of subjects: 120
Study 35773666 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study 34129666 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-borne rapid maxillary expansion (TB RME)
Number of subjects: 40
Study 34129666 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-borne rapid maxillary expansion (BB RME)
Number of subjects: 40
Study 34129666 — intervention group
Group type: COMPARATOR
Intervention: Comparison between TB RME and BB RME
Number of subjects: 40
Study 32678783 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile cues delivered through a wearable device
Number of subjects: 39
Study 32678783 — intervention group
Group type: COMPARATOR
Intervention: Visual signals
Number of subjects: 39
Study 32678783 — intervention group
Group type: COMPARATOR
Intervention: Visuo-tactile cues
Number of subjects: 39
Study 36384651 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Food Plant-Based (WFPB)
Number of subjects: 22
Study 36384651 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-Based Meat Alternatives (PBMA)
Number of subjects: 22
Study 36384651 — intervention group
Group type: COMPARATOR
Intervention: Omnivorous diet (Animal)
Number of subjects: 22
Study 32066404 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldilocks work principle intervention, involving participatory workshops and implementation of 'Goldilocks-games' for 10 weeks.
Number of subjects: 0